Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission
Gavrilova, I.E.; Kuznetsov, I.P.; Denisov, L.A.; Maiakova, S.A.; Orlova, T.G.; Kadagidze, Z.G.; Makhonova, L.A.
Pediatriia 11: 75-78
1991
ISSN/ISBN: 0031-403X PMID: 1766748 Document Number: 371741
The Soviet alpha-interferon drugs (human leukocytic interferon, reaferon) were used in the program of the treatment of children with acute lymphoblastic leukemia (during remission). The treatment was found to be more effective with an increase of its duration, relapse-free course of the disease (69.4-82.3%) and survival (70.1-93.1%) of patients with an unfavourable disease prognosis (over 5 years).
Document emailed within 1 workday
Related Documents
Kisliak, N.S.; Chernov, V.M.; Kondratchik, K.L.; Pronina, L.K.; Stolov, A.M. 1994: Duration of the first remission and survival rate of children with acute lymphoblastic leukemia after use of thymus preparations in the remission period Gematologiia i Transfuziologiia 39(5): 43-44Mokrzycka, M.łg.; Pawlik, A.; Kałdońska, M.; Millo, B. 2006: Assessment of liver function in children with acute lymphoblastic leukemia in remission Annales Academiae Medicae Stetinensis 52(3): 61
Zajaczkowski, J.; Pituch, A.; Kolanowska, H.; Michalik, R. 1975: Some immunological aspects of the long-term remission in acute lymphoblastic leukemia in children Folia Haematologica 102(4): 403-409
Manabe, A.; Yi, T.; Kumagai, M.; Campana, D. 1993: Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia Leukemia 7(12): 1990-1995
Kaftański, R. 1979: Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy Acta Haematologica Polonica 10(2): 99-106
Lin, W.; Xie, J.; Zhang, J.; Cheng, H.; Cui, H.; Zhang, Y.; Wu, Y.; Yu, J.; Qi, P.; Fan, J.; Gao, H.; Wang, F.; Zhang, R.; Zheng, H. 2019: Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study Minerva Pediatrica 2019
Aur, R.J.; Simone, J.V.; Verzosa, M.S.; Hustu, H.O.; Barker, L.F.; Pinkel, D.P. 1975: Comparison of four schedules of chemotherapy during remission of acute lymphoblastic leukemia in childhood Sangre 20(3): 237-244
Laila, R.; Islam, A.; Bhuiyan, M.M. 2016: Incidence of Hyperglycemia during Induction of Remission Phase of Pediatric Acute Lymphoblastic Leukemia Mymensingh Medical Journal: Mmj 25(4): 730-735
Ho, A.D.; Reichardt, P.; Gamm, H.; Hunstein, W. 1990: Pleural involvement in hairy cell leukemia--development under alpha-interferon and remission upon pentostatin therapy Leukemia 4(10): 720-721
Vey, N.; Blaise, D.; Stoppa, A.M.; Bouabdallah, R.; Lafage, M.; Sainty, D.; Cowen, D.; Viens, P.; Lepeu, G.; Blanc, A.P. 1994: Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission Bone Marrow Transplantation 14(3): 383-388
Andreasson, P.; Johansson, B.; Arheden, K.; Tedgård, U.; Ljung, R.; Heim, S.; Mitelmann, F. 1996: Emergence of novel transient clonal chromosomal bone marrow changes in remission of acute lymphoblastic leukemia Leukemia 10(2): 378-383
Devaraj, P.E.; Foroni, L.; Janossy, G.; Hoffbrand, A.V.; Secker-Walker, L.M. 1995: Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes Leukemia 9(5): 821-825
Hafiz, M.G.; Mannan, M.A. 2008: Nutritional status at initial presentation in childhood acute lymphoblastic leukemia and its effect on induction of remission Mymensingh Medical Journal: Mmj 17(2 Suppl): S46-S51
Porkhovatyĭ, S.I. 1982: Differential diagnosis of acute lymphoblastic leukemia and the lymphoblastic variant of lymphosarcoma in children Pediatriia 11: 19-23
Ladetto, M.; Corradini, P.; Astolfi, M.; Campana, S.; Tarella, C.; Pileri, A. 1996: Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia Haematologica 81(2): 159-161
Torres, A.; Martínez, F.; Gómez, P.; Fornés, G.; Rojas, R.; Herrera, C.; Gómez, J.L.; Manzanares, R.; García, J.M.; Andres, P. 1989: Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission Bone Marrow Transplantation 4(6): 609-612
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Mengarelli, A.; Iori, A.Paola.; Cerretti, R.; Cerilli, L.; Romano, A.; Arcese, W. 2002: Increasing risk of relapse after allogeneic stem cell transplant for adult acute lymphoblastic leukemia in > or = 2nd complete remission induced by highly intensive chemotherapy Haematologica 87(7): 782-784
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Cáp, J.; Foltinová, A.; Kaiserová, E.; Babusíková, O.; Jamárik, M.; Jasenková, M. 1998: Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children? Neoplasma 45(3): 135-139